About Qnovia
Qnovia is a company based in Richmond (United States) founded in 2018 by Mario Danek.. Qnovia has raised $38.12 million across 4 funding rounds from investors including Blue Ledge Capital, Evolution VC Partners and Vice Ventures. Qnovia offers products and services including Inhaled Drug Delivery Platform. Qnovia operates in a competitive market with competitors including MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Iconovo, among others.
- Headquarter Richmond, United States
- Founders Mario Danek
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Qnovia, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$38.12 M (USD)
in 4 rounds
-
Latest Funding Round
$16 M (USD), Series B
Oct 29, 2024
-
Investors
Blue Ledge Capital
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Qnovia
Qnovia offers a comprehensive portfolio of products and services, including Inhaled Drug Delivery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology for optimizing pharmaceutical delivery via inhalation to improve outcomes.
Unlock access to complete
Unlock access to complete
Funding Insights of Qnovia
Qnovia has successfully raised a total of $38.12M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $16 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $16.0M
-
First Round
First Round
(13 Jan 2020)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - Qnovia | Valuation | Blue Ledge Capital , Evolution VC Partners |
|
| Jun, 2023 | Amount | Series A - Qnovia | Valuation |
investors |
|
| Sep, 2022 | Amount | Series A - Qnovia | Valuation | Blue Ledge Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Qnovia
Qnovia has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Blue Ledge Capital, Evolution VC Partners and Vice Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in tech startups are made by Evolution VC Partners.
|
Founded Year | Domain | Location | |
|
Early stage venture capital fund focused on stigmatized industries is operated.
|
Founded Year | Domain | Location | |
|
Venture capital investing with a focus on diversity and inclusion in the ecosystem.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Qnovia
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Qnovia
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Qnovia Comparisons
Competitors of Qnovia
Qnovia operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Iconovo, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of small-molecule drugs
|
|
| domain | founded_year | HQ Location |
Developer of smart devices for nasal drug delivery
|
|
| domain | founded_year | HQ Location |
Intranasal delivery technology for CNS diseases is developed.
|
|
| domain | founded_year | HQ Location |
Developer of products for the treatment of acute and intermittent conditions
|
|
| domain | founded_year | HQ Location |
Inhalation devices for medical applications are developed by Iconovo.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Qnovia
Frequently Asked Questions about Qnovia
When was Qnovia founded?
Qnovia was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is Qnovia located?
Qnovia is headquartered in Richmond, United States. It is registered at Richmond, Virginia, United States.
Is Qnovia a funded company?
Qnovia is a funded company, having raised a total of $38.12M across 4 funding rounds to date. The company's 1st funding round was a Series A of $17M, raised on Jan 13, 2020.
What does Qnovia do?
Qnovia was founded in 2018 and is based in Richmond, United States. Inhaled drug delivery devices are developed by the company for a broad range of pharmaceuticals within the medtech sector. Operations focus on products such as RespiRx, a combination drug for inhalable nicotine replacement therapy aimed at smoking cessation, and a vibrating mesh nebulizer designed for lung-targeted delivery.
Who are the top competitors of Qnovia?
Qnovia's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.
What products or services does Qnovia offer?
Qnovia offers Inhaled Drug Delivery Platform.
Who are Qnovia's investors?
Qnovia has 6 investors. Key investors include Blue Ledge Capital, Evolution VC Partners, Vice Ventures, Gaingels, and DG Ventures.